Valuation: Nephros, Inc.

Market Cap 39.52M 34.55M 31.87M 29.3M 55.51M 3.8B 56.46M 381M 149M 1.86B 148M 145M 6.41B P/E 2026 *
80.9x
P/E 2027 * 36.4x
Enterprise Value 39.52M 34.55M 31.87M 29.3M 55.51M 3.8B 56.46M 381M 149M 1.86B 148M 145M 6.41B EV / Sales 2026 *
1.87x
EV / Sales 2027 * 1.71x
Free-Float
87.13%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer 51 2023-05-04
Director of Finance/CFO 60 2023-10-31
Chief Operating Officer - -
Director TitleAgeSince
Director/Board Member 69 2007-09-18
Director/Board Member 54 2018-08-09
Director/Board Member 58 2022-09-07
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-1.69% - - 39.52M
-3.99%-1.22% - - 17.01B
-0.51%+1.81%+27.86%+44.36% 10.35B
-2.83%+1.23%+167.90%+523.10% 4.7B
-3.98%-1.40%+60.36%+261.19% 4.49B
-6.38%-11.97%+122.11%+125.48% 1.64B
+12.29%-0.66% - - 1.32B
+0.14%-3.25%+156.25%+145.15% 972M
-0.19%+2.71%-17.45%-9.27% 936M
-2.55%+1.09%+131.00%+144.68% 819M
Average -0.81%-0.77%+92.58%+176.38% 4.69B
Weighted average by Cap. -2.39%-0.01%+74.94%+190.24%

Financials

2026 *2027 *
Net sales 21.08M 18.43M 17M 15.63M 29.62M 2.03B 30.12M 203M 79.65M 992M 79.18M 77.44M 3.42B 23.13M 20.22M 18.65M 17.15M 32.49M 2.23B 33.04M 223M 87.37M 1.09B 86.85M 84.94M 3.75B
Net income 517K 452K 417K 383K 726K 49.75M 739K 4.98M 1.95M 24.31M 1.94M 1.9M 83.81M 1.19M 1.04M 961K 884K 1.67M 115M 1.7M 11.48M 4.5M 56.06M 4.48M 4.38M 193M
Net Debt - -
Logo Nephros, Inc.
Nephros, Inc. is a water technology company providing filtration solutions to the medical and commercial markets. The Company provides water filtration products and services, along with water-quality education. In the medical markets, it sells water filtration products. In the commercial market, it manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, heavy metals, chemical compounds, scale build-up in downstream equipment, and various other contaminants. Its products are marketed primarily to the food service, hospitality, convenience store, and healthcare markets. These commercial products are also marketed in medical markets as supplemental filtration to its medical filters. Its filters are primarily used in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, and in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate.
Employees
-
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-